Anixa Biosciences(ANIX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ANIX Anixa Biosciences

美国独立日休市 07-02 16:00:00 EDT

3.27

+0.13

+4.14%

盘后3.28

+0.01+0.31%

19:50 EDT

最高3.48	最低3.15	成交量59.54万
今开3.20	昨收3.14	日振幅10.60%
总市值1.11亿	流通市值9,961万	总股本3,402万
成交额197.59万	换手率1.95%	流通股本3,046万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ANIX","market":"US","secType":"STK","nameCN":"Anixa Biosciences","latestPrice":3.27,"timestamp":1783022400000,"preClose":3.14,"halted":0,"volume":595414,"hourTrading":{"tag":"盘后","latestPrice":3.28,"preClose":3.27,"latestTime":"19:50 EDT","volume":1107,"amount":3644.424,"timestamp":1783036201027,"change":0.01,"changeRate":0.003058,"amplitude":0.025994},"delay":0,"changeRate":0.04140127388535028,"floatShares":30462667,"shares":34023100,"eps":-0.303504,"marketStatus":"美国独立日休市","change":0.13,"latestTime":"07-02 16:00:00 EDT","open":3.2,"high":3.4842,"low":3.1513,"amount":1975948.640782,"amplitude":0.106019,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.303504,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1783324800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":3.14,"preHourTrading":{"tag":"盘前","latestPrice":3.23,"preClose":3.14,"latestTime":"09:25 EDT","volume":4744,"amount":15111.105896000001,"timestamp":1782998713255,"change":0.09,"changeRate":0.028662,"amplitude":0.14793},"postHourTrading":{"tag":"盘后","latestPrice":3.28,"preClose":3.27,"latestTime":"19:50 EDT","volume":1107,"amount":3644.424,"timestamp":1783036201027,"change":0.01,"changeRate":0.003058,"amplitude":0.025994},"volumeRatio":1.224240963599947,"impliedVol":1.0086,"impliedVolPercentile":0.3904},"requestUrl":"/m/hq/s/ANIX","defaultTab":"news","newsList":[{"id":"1136687575","title":"Anixa Biosciences公布乳腺癌疫苗一期试验积极数据及CAR-T疗法一期试验生存期积极观察结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1136687575","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136687575?lang=zh_cn&edition=full","pubTime":"2026-06-26 21:10","pubTimestamp":1782479418,"startTime":"0","endTime":"0","summary":"在纽约科学院举办的“癌症免疫疗法前沿”研讨会上，Anixa Biosciences公布了其已完成的一期乳腺癌疫苗试验的积极数据，以及其正在进行的CAR-T疗法一期试验中观察到的积极生存期结果。该公司报告了其乳腺癌疫苗在一期临床试验中展现出的良好安全性与耐受性，同时观察到了初步的免疫反应信号。这些最新进展在专业学术会议上进行披露，凸显了Anixa Biosciences在癌症免疫治疗领域双管齐下的研发策略。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ANIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188966229","title":"Anixa Biosciences 报告 Lira-Cel 卵巢癌 CAR-T 疗法一期试验持续呈现积极生存观察结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1188966229","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188966229?lang=zh_cn&edition=full","pubTime":"2026-05-11 20:57","pubTimestamp":1778504238,"startTime":"0","endTime":"0","summary":"Anixa Biosciences 公布了其 Lira-Cel 卵巢癌 CAR-T 疗法一期临床试验的最新数据，持续观察到积极的生存结果。这项正在进行的试验为晚期卵巢癌患者带来了新的希望。\n数据显示，接受该创新疗法的患者群体在生存期方面展现出令人鼓舞的趋势。这些更新后的观察结果进一步支持了 Lira-Cel 疗法的潜在临床价值，并为后续研究奠定了基础。\n公司将继续推进该疗法的临床开发，旨在为缺乏有效治疗选择的卵巢癌患者提供一种新的治疗途径。持续的积极数据增强了业界对该 CAR-T 细胞疗法前景的信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ANIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140785473","title":"Anixa Biosciences 公司：前三个剂量组中未观察到剂量限制性毒性、ICANS或显著CRS","url":"https://stock-news.laohu8.com/highlight/detail?id=1140785473","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140785473?lang=zh_cn&edition=full","pubTime":"2026-05-11 20:57","pubTimestamp":1778504234,"startTime":"0","endTime":"0","summary":"Anixa Biosciences公司宣布，在其正在进行的临床试验中，前三个剂量组均未观察到剂量限制性毒性、免疫效应细胞相关神经毒性综合征或显著的细胞因子释放综合征。这一初步安全数据为后续更高剂量的探索提供了积极信号。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ANIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136800226","title":"Anixa Biosciences乳腺癌疫苗一期结果积极，推进至二期临床试验；Cytovance获选负责cGMP生产","url":"https://stock-news.laohu8.com/highlight/detail?id=1136800226","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136800226?lang=zh_cn&edition=full","pubTime":"2026-04-01 20:51","pubTimestamp":1775047871,"startTime":"0","endTime":"0","summary":"基于一期临床试验取得的积极成果，Anixa Biosciences（ANIX）已将其乳腺癌疫苗研发项目推进至二期临床阶段。与此同时，Cytovance生物制药公司被选定负责该疫苗的cGMP（现行药品生产质量管理规范）生产工作。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ANIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191961515","title":"Anixa Biosciences一期研究达到主要终点，在最大耐受剂量下展现安全性与耐受性","url":"https://stock-news.laohu8.com/highlight/detail?id=1191961515","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191961515?lang=zh_cn&edition=full","pubTime":"2026-04-01 20:51","pubTimestamp":1775047871,"startTime":"0","endTime":"0","summary":"Anixa Biosciences公司宣布，其一项一期临床试验已成功达成预设的主要研究终点。该试验数据表明，在最大耐受剂量下，所研究的疗法表现出良好的安全性和耐受性特征。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ANIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100829234","title":"Anixa Biosciences将在妇科肿瘤学会年度女性癌症大会上公布其卵巢癌CAR-T疗法临床试验数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1100829234","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100829234?lang=zh_cn&edition=full","pubTime":"2026-03-30 21:08","pubTimestamp":1774876119,"startTime":"0","endTime":"0","summary":"Anixa Biosciences宣布，其针对卵巢癌的CAR-T疗法临床试验结果，将于妇科肿瘤学会（SGO）年度女性癌症大会上正式发布。这一重要进展凸显了公司在创新癌症免疫治疗领域的持续探索。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ANIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129098022","title":"Anixa Biosciences将召开2026年股东年会，并发布公司更新，重点介绍近期临床与监管进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1129098022","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129098022?lang=zh_cn&edition=full","pubTime":"2026-03-02 22:11","pubTimestamp":1772460671,"startTime":"0","endTime":"0","summary":"Anixa Biosciences宣布，公司将举办2026年度股东大会。\n届时，管理层将向股东汇报公司最新动态，重点展示在临床试验和监管事务方面取得的重要进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANIX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138765222","title":"Anixa Biosciences卵巢癌CAR-T疗法试验获积极患者生存数据，监管批准实现重大剂量递增","url":"https://stock-news.laohu8.com/highlight/detail?id=1138765222","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138765222?lang=zh_cn&edition=full","pubTime":"2026-02-09 21:03","pubTimestamp":1770642237,"startTime":"0","endTime":"0","summary":"Anixa Biosciences宣布，其针对卵巢癌的CAR-T细胞疗法临床试验取得鼓舞人心的患者生存观察结果。公司同时获得监管机构批准，得以实施重大剂量递增方案，为后续疗效评估提供关键支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ANIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147079761","title":"Anixa Biosciences 获得美国采纳名称委员会对其CAR-T疗法非专利名称的批准，迈出未来商业化关键一步","url":"https://stock-news.laohu8.com/highlight/detail?id=1147079761","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147079761?lang=zh_cn&edition=full","pubTime":"2026-02-02 22:07","pubTimestamp":1770041233,"startTime":"0","endTime":"0","summary":"Anixa Biosciences宣布，其CAR-T疗法已获得美国采纳名称委员会对非专利名称的批准。CAR-T疗法作为一种创新的癌症治疗方法，通过改造患者自身的T细胞来靶向并摧毁癌细胞，近年来在肿瘤治疗领域展现出巨大潜力。此次非专利名称的获批，不仅为Anixa Biosciences后续的临床试验、专利申请以及市场推广奠定了基础，也进一步增强了投资者对公司研发管线进展的信心。公司表示，将继续推进该疗法的临床开发工作，并积极筹备后续的商业化战略。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ANIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518559277","title":"Anixa Biosciences, Inc.盘中异动 股价大跌5.63%报2.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518559277","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518559277?lang=zh_cn&edition=full","pubTime":"2025-03-10 23:45","pubTimestamp":1741621555,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日23时45分，Anixa Biosciences, Inc.股票出现波动，股价大幅下跌5.63%。Anixa Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。其相关个股中，Aeon Biopharma, Inc.、Mineralys Therapeutics, Inc.、Checkpoint Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Aeon Biopharma, Inc.、Scisparc Ltd.较为活跃，换手率分别为3641.67%、2398.05%、826.28%，振幅较大的相关个股有Aeon Biopharma, Inc.、Scisparc Ltd.、Dogwood Therapeutics, Inc.，振幅分别为78.32%、49.87%、41.36%。Anixa Biosciences, Inc.公司简介：Anixa Biosciences Inc 是一家专注于癌症的生物技术公司，开发疫苗和疗法，专注于肿瘤领域未满足的关键需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503102345569640533d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503102345569640533d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517985225","title":"Anixa Biosciences, Inc.盘中异动 股价大涨5.28%报2.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517985225","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517985225?lang=zh_cn&edition=full","pubTime":"2025-03-05 04:29","pubTimestamp":1741120197,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日04时29分，Anixa Biosciences, Inc.股票出现波动，股价急速上涨5.28%。Anixa Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.24%。Anixa Biosciences, Inc.公司简介：Anixa Biosciences Inc 是一家专注于癌症的生物技术公司，开发疫苗和疗法，专注于肿瘤领域未满足的关键需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305042957abe854b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305042957abe854b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANIX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513727017","title":"Anixa Biosciences, Inc.盘中异动 早盘急速跳水5.19%报2.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513727017","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513727017?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:01","pubTimestamp":1740409260,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时01分，Anixa Biosciences, Inc.股票出现异动，股价大幅下挫5.19%。Anixa Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。其相关个股中，Pepgen Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Telix Pharmaceutic涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为153.98%、68.47%、25.12%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ，振幅分别为137.23%、55.69%、41.14%。Anixa Biosciences, Inc.公司简介：Anixa Biosciences Inc 是一家专注于癌症的生物技术公司，开发疫苗和疗法，专注于肿瘤领域未满足的关键需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230100962ea038&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230100962ea038&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512431796","title":"Anixa Biosciences, Inc.盘中异动 大幅下挫5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512431796","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512431796?lang=zh_cn&edition=full","pubTime":"2025-02-20 05:00","pubTimestamp":1739998850,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日05时00分，Anixa Biosciences, Inc.股票出现异动，股价大幅跳水5.20%。Anixa Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.89%。其相关个股中，Editas Medicine, Inc.、Osr Holdings, Inc.、Osr Holdings Inc C/Wts 02/09/2028 涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为721.67%、261.95%、236.99%，振幅较大的相关个股有Osr Holdings Inc C/Wts 02/09/2028 、Surrozen Inc C/Wts 01/08/2031 、Osr Holdings, Inc.，振幅分别为288.38%、280.70%、160.77%。Anixa Biosciences, Inc.公司简介：Anixa Biosciences Inc 是一家专注于癌症的生物技术公司，开发疫苗和疗法，专注于肿瘤领域未满足的关键需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022005005196290acb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022005005196290acb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509420118","title":"Anixa Biosciences, Inc.盘中异动 大幅上涨5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509420118","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509420118?lang=zh_cn&edition=full","pubTime":"2025-02-07 01:18","pubTimestamp":1738862309,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日01时18分，Anixa Biosciences, Inc.股票出现异动，股价急速上涨5.33%。Anixa Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。其相关个股中，Lipella Pharmaceuticals Inc.、Palatin Technologies, Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Azitra Inc较为活跃，换手率分别为6103.93%、1623.39%、162.97%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Palatin Technologies, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为125.58%、58.37%、53.02%。Anixa Biosciences, Inc.公司简介：Anixa Biosciences Inc 是一家专注于癌症的生物技术公司，开发疫苗和疗法，专注于肿瘤领域未满足的关键需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207011829abc4f666&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207011829abc4f666&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANIX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508493511","title":"Anixa Biosciences, Inc.盘中异动 早盘股价大跌5.69%报2.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508493511","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508493511?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:38","pubTimestamp":1738593503,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时38分，Anixa Biosciences, Inc.股票出现波动，股价快速下挫5.69%。截至发稿，该股报2.74美元/股，成交量1.4818万股，换手率0.05%，振幅0.00%。Anixa Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.39%。Anixa Biosciences, Inc.公司简介：Anixa Biosciences Inc 是一家专注于癌症的生物技术公司，开发疫苗和疗法，专注于肿瘤领域未满足的关键需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223824abc108c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223824abc108c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507548810","title":"Anixa Biosciences, Inc.盘中异动 早盘股价大涨6.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507548810","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507548810?lang=zh_cn&edition=full","pubTime":"2025-01-28 22:34","pubTimestamp":1738074872,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日22时34分，Anixa Biosciences, Inc.股票出现波动，股价大幅上涨6.92%。Anixa Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。其相关个股中，Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Hepion Pharmaceuticals, Inc.涨幅较大，Hepion Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为701.42%、222.83%、151.36%，振幅较大的相关个股有Tonix Pharmaceuticals Holding Corp.、Allarity Therapeutics, Inc.、Zymeworks Inc.，振幅分别为113.08%、103.25%、101.04%。Anixa Biosciences, Inc.公司简介：Anixa Biosciences Inc 是一家专注于癌症的生物技术公司，开发疫苗和疗法，专注于肿瘤领域未满足的关键需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128223433abbb666f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128223433abbb666f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANIX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505590862","title":"Anixa Biosciences, Inc.盘中异动 早盘股价大跌5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505590862","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505590862?lang=zh_cn&edition=full","pubTime":"2025-01-24 23:38","pubTimestamp":1737733094,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日23时38分，Anixa Biosciences, Inc.股票出现异动，股价快速下挫5.48%。Anixa Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.45%。其相关个股中，Evaxion Biotech As、Pmgc Holdings Inc.、Transcode Therapeutics, Inc.涨幅较大，Evaxion Biotech As、Pmgc Holdings Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为3558.88%、1861.71%、1358.91%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Evaxion Biotech As、Windtree Therapeutics, Inc.，振幅分别为134.08%、112.09%、66.25%。Anixa Biosciences, Inc.公司简介：Anixa Biosciences Inc 是一家专注于癌症的生物技术公司，开发疫苗和疗法，专注于肿瘤领域未满足的关键需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124233815a22e6999&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124233815a22e6999&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505279012","title":"Anixa Biosciences, Inc.盘中异动 股价大涨7.88%报2.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505279012","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505279012?lang=zh_cn&edition=full","pubTime":"2025-01-21 22:33","pubTimestamp":1737469988,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日22时33分，Anixa Biosciences, Inc.股票出现异动，股价大幅拉升7.88%。截至发稿，该股报2.60美元/股，成交量4.3716万股，换手率0.14%，振幅1.04%。Anixa Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.89%。Anixa Biosciences, Inc.公司简介：Anixa Biosciences Inc 是一家专注于癌症的生物技术公司，开发疫苗和疗法，专注于肿瘤领域未满足的关键需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223308abb34708&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223308abb34708&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504197539","title":"Anixa Biosciences, Inc.盘中异动 急速下挫5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504197539","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504197539?lang=zh_cn&edition=full","pubTime":"2025-01-18 01:49","pubTimestamp":1737136140,"startTime":"0","endTime":"0","summary":"北京时间2025年01月18日01时49分，Anixa Biosciences, Inc.股票出现异动，股价快速跳水5.04%。Anixa Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.75%。Anixa Biosciences, Inc.公司简介：Anixa Biosciences Inc 是一家专注于癌症的生物技术公司，致力于开发那些肿瘤学中未满足的关键需求的疫苗和疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118014900abaedc33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118014900abaedc33&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503916193","title":"Anixa Biosciences, Inc.盘中异动 早盘股价大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503916193","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503916193?lang=zh_cn&edition=full","pubTime":"2025-01-16 23:11","pubTimestamp":1737040269,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日23时11分，Anixa Biosciences, Inc.股票出现异动，股价大幅上涨5.09%。Anixa Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.90%。Anixa Biosciences, Inc.公司简介：Anixa Biosciences Inc 是一家专注于癌症的生物技术公司，致力于开发那些肿瘤学中未满足的关键需求的疫苗和疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116231110960610f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116231110960610f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANIX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.anixa.com","stockEarnings":[{"period":"1week","weight":0.2481},{"period":"1month","weight":0.2824},{"period":"3month","weight":0.2824},{"period":"6month","weight":0.0348},{"period":"1year","weight":0.0251},{"period":"ytd","weight":0.0481}],"compareEarnings":[{"period":"1week","weight":0.0143},{"period":"1month","weight":-0.0195},{"period":"3month","weight":0.1356},{"period":"6month","weight":0.0902},{"period":"1year","weight":0.2004},{"period":"ytd","weight":0.0922}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Anixa Biosciences, Inc.根据特拉华州法律于1982年11月5日注册成立，是一家生物技术公司，致力于开发针对肿瘤和传染病的关键未满足需求的疗法和疫苗。公司的主要业务是开发嵌合内分泌受体T细胞技术以及发现和最终开发抗癌药物-用于治疗COVID-19的病毒候选药物集中于抑制病毒的某些病毒蛋白功能。","yearOnYearQuotes":[{"month":1,"riseRate":0.727273,"avgChangeRate":0.14227},{"month":2,"riseRate":0.272727,"avgChangeRate":-0.055581},{"month":3,"riseRate":0.181818,"avgChangeRate":-0.072942},{"month":4,"riseRate":0.363636,"avgChangeRate":-0.00589},{"month":5,"riseRate":0.363636,"avgChangeRate":-0.087307},{"month":6,"riseRate":0.454545,"avgChangeRate":0.047053},{"month":7,"riseRate":0.727273,"avgChangeRate":0.098753},{"month":8,"riseRate":0.545455,"avgChangeRate":0.006342},{"month":9,"riseRate":0.636364,"avgChangeRate":0.312097},{"month":10,"riseRate":0.363636,"avgChangeRate":0.031849},{"month":11,"riseRate":0.363636,"avgChangeRate":-0.010369},{"month":12,"riseRate":0.363636,"avgChangeRate":-0.073586}],"exchange":"NASDAQ","name":"Anixa Biosciences","nameEN":"Anixa Biosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Anixa Biosciences(ANIX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Anixa Biosciences(ANIX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Anixa Biosciences,ANIX,Anixa Biosciences股票,Anixa Biosciences股票老虎,Anixa Biosciences股票老虎国际,Anixa Biosciences行情,Anixa Biosciences股票行情,Anixa Biosciences股价,Anixa Biosciences股市,Anixa Biosciences股票价格,Anixa Biosciences股票交易,Anixa Biosciences股票购买,Anixa Biosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Anixa Biosciences(ANIX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Anixa Biosciences(ANIX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}